Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Derivative Claim - Update

2 Oct 2014 07:00

RNS Number : 2328T
Elektron Technology PLC
02 October 2014
 



2 October 2014

 

Elektron Technology plc

(AIM: EKT, "Elektron" or "the Company" or the "Group")

 

Derivative Claim - Update

 

In its 2014 Annual Report the Company disclosed derivative litigation with a shareholder Mr B. Bridge, who holds at the date of this announcement 1.83 % of the Company's ordinary shares. For convenience, this disclosure is repeated in Appendix 1.

 

As announced on 23 June 2014, the Court had listed Mr Bridge's application for permission to continue the claim, for a one day hearing on 1 October 2014.

 

Despite yesterday's hearing being listed six months in advance, Mr Bridge only formally appointed legal advisors to represent him on 11 September 2014, less than three weeks before the hearing. He also indicated an intention to reformulate the claim to address perceived deficiencies in it. As a consequence much of yesterday's hearing was devoted to considering a request by Mr Bridge to adjourn the hearing.

 

The resulting judgment was:

 

1. Permission to continue a claim against Tony Harris and Ric Piper was refused (pursuant to s. 261(2) Companies Act 2006) on the basis that Mr Bridge had failed to establish a case against them that they could be required to answer. Mr Bridge was ordered to pay both Tony Harris and Ric Piper's specific costs;

 

2. The hearing of the application for permission to continue the claim against the remaining directors was not considered, but adjourned to a later date. In the meantime the proceedings will be stayed to 30 November 2014 to enable the parties to consider alternative dispute resolution;

 

3. Mr Bridge to serve draft amended particulars of claim by 19 December 2014, seeking the consent of the Company and the directors to admit the same;

 

4. A directions hearing to be listed in the week commencing 26 January 2015 in the High Court in London;

 

5. The wasted costs of the Company and the directors in preparing for and attending yesterday's hearing be paid by Mr Bridge, to be assessed if not agreed, as the court was satisfied that Mr Bridge's late appointment of legal advisors was tactical, and his stance in seeking an adjournment disingenuous and opportunistic;

 

6. Mr Bridge to make interim payments in the sums of £5,000 plus VAT in respect of the directors' costs and £5,000 in respect of the Company's costs within 28 days;

 

7. All other costs reserved to be addressed at the adjourned substantive hearing of Mr Bridge's application for permission to continue the claim against Keith Daley, John Wilson, Noah Franklin and Simon Acland.

 

Further updates will be provided in due course.

 

Appendix 1 - Potential litigation

As disclosed in the 2014 Annual Report on page 16.

A shareholder, Mr B Bridge, has issued proceedings under The Companies Act 2006 (the 'Act') in the Liverpool District Registry of the High Court seeking permission to pursue a derivative claim against certain directors of the Company, (namely Keith Daley, Tony Harris, Ric Piper and John Wilson) and certain former directors (namely Noah Franklin and Simon Acland), collectively the 'Directors'.

 

The Act provides a means by which an individual shareholder of a company may bring proceedings in respect of a claim which vests in, and in which a remedy is sought on behalf of, the Company. This is known as a derivative claim.

 

Where a shareholder seeks to bring a derivative claim, the Act imposes a filtering process by which the claim can only be continued if the Court grants permission. The shareholder must make the Company a defendant to the proceedings for the purpose of the permission stage and Mr Bridge has done this.

The Court has listed Mr Bridge's permission application for a one day hearing on 1 October 2014. If the claim is continued it would be expected to come to Court in 2015 or 2016.

 

The Company has instructed solicitors and counsel to advise and represent it. It should be noted that, although a party to the proceedings at this time, the Company will only have a limited, neutral role and that the permission hearing will be conducted principally between Mr Bridge and the Directors. The Court is obliged to refuse permission for a derivative action to proceed if a person acting under a general duty to promote the success of the company would not seek to continue the claim.

 

The Company has received professional advice that, on the evidence, the Court is at the moment more likely to refuse, than to grant, permission. This advice is subject to on-going review.

 

In summary, Mr Bridge is alleging various breaches of duty by the Directors, including dishonesty, 'a reckless acquisition spree', illegal share price manipulation and the implementation of unfair bonus and share schemes without proper shareholder approval.

 

The Directors refute the allegations made by Mr Bridge and have instructed their own solicitors and counsel.

 

Enquiries:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

Andy Weatherstone - Chief Finance Officer

Martin Reeves - Company Secretary

finnCap (Nominated Adviser, Financial Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Ben Thompson (Corporate Finance)

Malar Velaigam (Corporate Broking)

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Kay Larsen

 

Notes to Editors

 

Elektron conceives designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas:

 

· New waves of "aware" business applications: Internet of Things

· Demand for ubiquitous power and data: Connectivity Solutions

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition it owns a portfolio of well-established products and brands which provide customer access and feedback.

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFVFIRLLIIS
Date   Source Headline
3rd Jun 20269:53 amRNSForm 8.5 (EPT/RI)
2nd Jun 20269:57 amRNSForm 8.5 (EPT/RI)
1st Jun 202611:33 amRNSForm 8.5 (EPT/RI)
1st Jun 20267:00 amRNSUpdate: Formal Sale Process
29th May 202610:37 amRNSForm 8.5 (EPT/RI)
27th May 20269:50 amRNSForm 8.5 (EPT/RI) - Checkit PLC
26th May 202610:52 amRNSForm 8.5 (EPT/RI)
22nd May 20262:37 pmRNSResult of AGM
22nd May 202610:49 amRNSForm 8.5 (EPT/RI)
22nd May 20267:00 amRNSAGM Update: Formal Sale Process
21st May 202610:18 amRNSForm 8.5 (EPT/RI) - Checkit PLC
20th May 20262:40 pmRNSForm 8.5 (EPT/RI)
20th May 20262:32 pmEQSForm 8.3 - Checkit PLC
19th May 202611:59 amRNSForm 8.5 (EPT/RI) - Checkit PLC
18th May 202611:04 amRNSForm 8.5 (EPT/RI)
15th May 20269:07 amRNSForm 8.5 (EPT/RI)
14th May 20262:28 pmRNSForm 8.5 (EPT/RI)
12th May 202610:10 amRNSForm 8.5 (EPT/RI)
11th May 20261:39 pmRNSForm 8.5 (EPT/RI)
8th May 20269:54 amRNSForm 8.5 (EPT/RI)
7th May 202611:09 amRNSForm 8.5 (EPT/RI)
6th May 20269:50 amRNSForm 8.5 (EPT/RI)
5th May 202610:06 amRNSForm 8.5 (EPT/RI)
1st May 202611:57 amRNSForm 8.5 (EPT/RI) - Checkit PLC
28th Apr 202610:00 amRNSForm 8.5 (EPT/RI)
27th Apr 202611:31 amRNSPosting of Annual Report and Notice of AGM
27th Apr 202610:26 amRNSForm 8.5 (EPT/RI) - Checkit PL
24th Apr 202610:46 amRNSForm 8.5 (EPT/RI)
23rd Apr 202611:33 amEQSForm 8.3 -Checkit PLC
23rd Apr 202611:17 amRNSForm 8.5 (EPT/RI) - Checkit PLC
22nd Apr 202610:10 amRNSForm 8.5 (EPT/RI)
21st Apr 202610:23 amRNSForm 8.5 (EPT/RI)
21st Apr 20267:00 amRNSFinal Results
20th Apr 202610:34 amRNSForm 8.5 (EPT/RI) - Replacement
20th Apr 20269:53 amRNSForm 8.5 (EPT/RI)
17th Apr 202610:37 amEQSForm 8.3 - Checkit PLC
17th Apr 20269:37 amRNSForm 8.5 (EPT/RI)
16th Apr 202610:48 amRNSForm 8.3 - Checkit PLC
16th Apr 20269:57 amRNSForm 8.5 (EPT/RI)
15th Apr 20269:31 amRNSForm 8.5 (EPT/RI)
14th Apr 20262:00 pmEQSForm 8.3 - Checkit plc
14th Apr 202610:03 amRNSForm 8.5 (EPT/RI)
13th Apr 20262:29 pmEQSForm 8.3 - Checkit plc
13th Apr 202611:46 amRNSForm 8.5 (EPT/RI)
10th Apr 202612:47 pmEQSForm 8.3 - Checkit PLC
10th Apr 202611:58 amRNSForm 8.5 (EPT/RI)
9th Apr 202611:34 amRNSForm 8.5 (EPT/RI)
9th Apr 20268:04 amEQSForm 8.3 - Checkit PLC
8th Apr 202612:51 pmRNSForm 8.3 - Checkit PLC
8th Apr 202612:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.